Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ORSKOV C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jensen, H; Orskov, C; Rehfeld, JF; Johnsen, AH
      A processing enzyme cleaving avian progastrin at post-Phe bonds

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    2. Thulesen, J; Hartman, B; Kissow, H; Jeppsen, PK; Orskov, C; Holst, JJ; Poulsen, SS
      Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal-jejunal transposition or small bowel resection

      DIGESTIVE DISEASES AND SCIENCES
    3. Holst, JJ; Orskov, C
      Incretin hormones - an update

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    4. Sams-Nielsen, A; Orskov, C; Jansen-Olesen, I
      Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals

      BRITISH JOURNAL OF PHARMACOLOGY
    5. Thulesen, J; Hartmann, B; Orskov, C; Jeppesen, PB; Holst, JJ; Poulsen, SS
      Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected I-125-GLP-2

      PEPTIDES
    6. Hartmann, B; Johnsen, AH; Orskov, C; Adelhorst, K; Thim, L; Holst, JJ
      Structure, measurement, and secretion of human glucagon-like peptide-2

      PEPTIDES
    7. Hartmann, B; Thulesen, J; Kissow, H; Thulesen, S; Orskov, C; Ropke, C; Poulsen, SS; Holst, JJ
      Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect ofglucagon-like peptide-2 rats and mice

      ENDOCRINOLOGY
    8. Hansen, L; Deacon, CF; Orskov, C; Holst, JJ
      Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying theL cells of the porcine intestine

      ENDOCRINOLOGY
    9. HJORTH SA; ORSKOV C; SCHWARTZ TW
      CONSTITUTIVE ACTIVITY OF GLUCAGON RECEPTOR MUTANTS

      Molecular endocrinology
    10. NAUCK MA; WEBER I; BACH I; RICHTER S; ORSKOV C; HOLST JJ; SCHMIEGEL W
      NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 ([7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS

      Diabetic medicine
    11. HOLST JJ; HANSEN L; ORSKOV C; WOJDEMANN M; WETIERGREN A; DEACON CF
      GLP-1 (7-36AMIDE) IS TRANSFORMED BY DIPEPTIDYL PEPTIDASE-IV IN THE CAPILLARIES SUPPLYING THE L-CELLS INTO GLP-1 (9-36AMIDE), WHICH ANTAGONIZES THE GASTROINTESTINAL EFFECTS OF GLP-1

      Diabetes
    12. LARSEN PJ; TANGCHRISTENSEN M; HOLST JJ; ORSKOV C
      DISTRIBUTION OF GLUCAGON-LIKE PEPTIDE-1 AND OTHER PREPROGLUCAGON-DERIVED PEPTIDES IN THE RAT HYPOTHALAMUS AND BRAIN-STEM

      Neuroscience
    13. NAUCK MA; NIEDEREICHHOLZ U; ETTLER R; HOLST JJ; ORSKOV C; RITZEL R; SCHMIEGEL WH
      GLUCAGON-LIKE PEPTIDE-1 INHIBITION OF GASTRIC-EMPTYING OUTWEIGHS ITS INSULINOTROPIC EFFECTS IN HEALTHY HUMANS

      American journal of physiology: endocrinology and metabolism
    14. HOLST A; ORSKOV C; WETTERGREN AW; WOJDEMANN M
      INTESTINAL ENDOCRINE SIGNALS TO THE CNS

      Gut
    15. NAUCK MA; KEMMERIES G; GROSSER S; ORSKOV C; HOLST JJ; SCHMIEGEL W
      RAPID TACHYPHYLAXIS FOR THE DECELERATION OF GASTRIC-EMPTYING BY EXOGENOUS GLP-1

      Gastroenterology
    16. THULESEN J; ORSKOV C; HOLST JJ; POULSEN SS
      SHORT-TERM INSULIN-TREATMENT PREVENTS THE DIABETOGENIC ACTION OF STREPTOZOTOCIN IN RATS

      Endocrinology
    17. CREUTZFELDT WOC; ORSKOV C; KLEINE N; HOLST JJ; WILLMS B; NAUCK MA
      GLUCAGONOSTATIC ACTIONS AND REDUCTION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE I(7-36) AMIDE IN TYPE-I DIABETIC-PATIENTS

      Diabetes care
    18. NAUCK MA; SIEMSGLUSS J; ORSKOV C; HOLST JJ
      RELEASE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1 [7-36-AMIDE]), GASTRIC-INHIBITORY POLYPEPTIDE (GIP) AND INSULIN IN RESPONSE TO ORAL GLUCOSE AFTERUPPER AND LOWER INTESTINAL RESECTIONS

      Zeitschrift fur Gastroenterologie
    19. ORSKOV C; WETTERGREN A; HOLST JJ
      SECRETION OF THE INCRETIN HORMONES GLUCAGON-LIKE PEPTIDE-1 AND GASTRIC-INHIBITORY POLYPEPTIDE CORRELATES WITH INSULIN-SECRETION IN NORMAL MAN THROUGHOUT THE DAY

      Scandinavian journal of gastroenterology
    20. WILLMS B; WERNER J; HOLST JJ; ORSKOV C; CREUTZFELDT W; NAUCK MA
      GASTRIC-EMPTYING GLUCOSE RESPONSES, AND INSULIN-SECRETION AFTER A LIQUID TEST MEAL - EFFECTS OF EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)-(7-36) AMIDE IN TYPE-2 (NONINSULIN-DEPENDENT) DIABETIC-PATIENTS

      The Journal of clinical endocrinology and metabolism
    21. NAUCK MA; GROSSER S; KEMMERIES G; ORSKOV C; HOLST JJ; SCHMIEGEL W
      ERYTHROMYCIN, BUT NOT METOCLOPRAMIDE, DOMPERIDONE, OR CISAPRIDE ANTAGONIZE THE INHIBITION OF GASTRIC-EMPTYING BY GLP-1 IN HEALTHY-VOLUNTEERS

      Gastroenterology
    22. NAUCK MA; NIEDEREICHHOLZ U; ETTLER R; ORSKOV C; HOLST JJ; SCHMIEGEL W
      EVIDENCE AGAINST A PHYSIOLOGICAL-ROLE OF GLP-1 AS AN INSULINOTROPIC INCRETIN HORMONE IN HEALTHY-VOLUNTEERS

      Gastroenterology
    23. NAUCK MA; WOLLSCHLAGER D; WERNER J; HOLST JJ; ORSKOV C; CREUTZFELDT W; WILLMS B
      EFFECTS OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1 [7-36 AMIDE]) IN PATIENTS WITH NIDDM

      Diabetologia
    24. ORSKOV L; HOLST JJ; MOLLER J; ORSKOV C; MOLLER N; ALBERTI KGMM; SCHMITZ O
      GLP-1 DOES NOT ACUTELY AFFECT INSULIN SENSITIVITY IN HEALTHY MAN

      Diabetologia
    25. NAUCK MA; GROSSER S; KEMMERIES G; ORSKOV C; HOLST JJ; SCHMIEGEL W
      ERYTHROMYCIN ANTAGONIZES THE INHIBITION OF GASTRIC-EMPTYING BY GLP-1 AND UNMASKS IT POSTPRANDIAL INSULINOTROPIC ACROSS

      Diabetologia
    26. ORSKOV C; POULSEN SS; MOLLER M; HOLST JJ
      GLUCAGON-LIKE PEPTIDE-I RECEPTORS IN THE SUBFORNICAL ORGAN AND THE AREA POSTREMA ARE ACCESSIBLE TO CIRCULATING GLUCAGON-LIKE PEPTIDE-I

      Diabetes
    27. ORSKOV C; TANGCHRISTENSEN M; HOLST JJ; LARSEN PJ
      DISTRIBUTION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AND OTHER PREPROGLUCAGON DERIVED PEPTIDES IN THE RAT HYPOTHALAMUS AND BRAIN-STEM

      Diabetes
    28. HEINZE E; HOLL RW; CLARK PMS; HALES CN; ORSKOV C; EBERT R
      THE ENTEROINSULAR AXIS IN WOMEN WITH TURNER-SYNDROME (TS) AND NORMAL ORAL GLUCOSE-TOLERANCE

      Diabetes
    29. HARTMANN B; JOHNSEN AH; ORSKOV C; HOLST JJ
      STRUCTURE, ANALYSIS AND SECRETION OF HUMAN GLUCAGON-LIKE PEPTIDE-2 (GLP-2)

      Diabetes
    30. QUALMANN C; NAUCK MA; HOLST JJ; ORSKOV C; CREUTZFELDT W
      INSULINOTROPIC ACTIONS OF INTRAVENOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1)[7-36-AMIDE] IN THE FASTING STATE IN HEALTHY-SUBJECTS

      Acta diabetologica
    31. FIESELER P; BRIDENBAUGH S; NUSTEDE R; MARTELL J; ORSKOV C; HOLST JJ; NAUCK MA
      PHYSIOLOGICAL AUGMENTATION OF AMINO ACID-INDUCED INSULIN-SECRETION BYGIP AND GLP-I BUT NOT BY CCK-8

      American journal of physiology: endocrinology and metabolism
    32. QUALMANN C; NAUCK MA; HOLST JJ; ORSKOV C; CREUTZFELDT W
      GLUCAGON-LIKE PEPTIDE-1 (7-36-AMIDE) SECRETION IN RESPONSE TO LUMINALSUCROSE FROM THE UPPER AND LOWER GUT - A STUDY USING ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE)

      Scandinavian journal of gastroenterology
    33. RITZEL R; ORSKOV C; HOLST JJ; NAUCK MA
      PHARMACOKINETIC, INSULINOTROPIC, AND GLUCAGONOSTATIC PROPERTIES OF GLP-1 [7-36-AMIDE] AFTER SUBCUTANEOUS INJECTION IN HEALTHY-VOLUNTEERS - DOSE-RESPONSE-RELATIONSHIPS

      Diabetologia
    34. NAUCK MA; WOLLSCHLAGER D; WERNER J; HOLST JJ; ORSKOV C; CREUTZFELDT W; WILLMS B
      EFFECTS OF SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1[7-36 AMIDE]) IN PATIENTS WITH TYPE-2-DIABETES

      Diabetologia
    35. ORSKOV C; WETTERGREN A; POULSEN SS; HOLST JJ
      IS THE EFFECT OF GLUCAGON-LIKE PEPTIDE-1 ON GASTRIC-EMPTYING CENTRALLY MEDIATED

      Diabetologia
    36. RITZEL R; ORSKOV C; HOLST JJ; SCHMIEGEL W; NAUCK M
      GLP-1 [7-36 AMIDE] AUGMENTS BIPHASIC INSULIN-SECRETION AFTER INTRAVENOUS GLUCOSE IN HEALTHY-VOLUNTEERS

      Diabetologia
    37. WILLMS B; KLEINE N; CREUTZFELDT W; ORSKOV C; HOLST J; NAUCK M
      GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) LOWERS BLOOD-GLUCOSE ALSO IN TYPE-1 DIABETIC-PATIENTS

      Diabetologia
    38. HARTMANN B; ORSKOV C; WETTERGREN A; HOLST JJ
      DIURNAL PROFILES OF GLUCAGON-LIKE PEPTIDE-1 AND PEPTIDE-2 (GLP-1 AND GLP-2) IN NORMAL MAN

      Diabetologia
    39. ORSKOV L; HOLST JJ; MOLLER J; ORSKOV C; MOLLER N; SCHMITZ O
      ACUTE GLP-1 ADMINISTRATION DOES NOT AFFECT INSULIN SENSITIVITY IN HEALTHY MAN

      Diabetologia
    40. MINEO H; SCHMIDT P; ORSKOV C; HOLST JJ
      EFFECTS OF LUMINAL STIMULI ON GLUCAGON-LIKE PEPTIDE-1 AND PEPTIDE-YY RELEASE FROM THE ISOLATED-PERFUSED PIG ILEUM

      Diabetologia
    41. WEBER I; BACHESSER AK; BACH I; RICHTER S; ORSKOV C; HOLST JJ; SCHMIEGEL W; NAUCK MA
      PROLONGED NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 (]7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS

      Diabetologia
    42. WETTERGREN A; PETERSEN H; ORSKOV C; CHRISTIANSEN J; SHEIKH SP; HOLST JJ
      GLUCAGON-LIKE PEPTIDE-1 7-36-AMIDE AND PEPTIDE-YY FROM THE L-CELL OF THE ILEAL-MUCOSA ARE POTENT INHIBITORS OF VAGALLY INDUCED GASTRIC-ACIDSECRETION IN MAN

      Scandinavian journal of gastroenterology
    43. HVIDBERG A; NIELSEN MT; HILSTED J; ORSKOV C; HOLST JJ
      EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (PROGLUCAGON 78-107AMIDE) ON HEPATIC GLUCOSE-PRODUCTION IN HEALTHY MAN

      Metabolism, clinical and experimental
    44. HOLST JJ; BERSANI M; JOHNSEN AH; KOFOD H; HARTMANN B; ORSKOV C
      PROGLUCAGON PROCESSING IN PORCINE AND HUMAN PANCREAS

      The Journal of biological chemistry
    45. ANDREASEN JJ; ORSKOV C; HOLST JJ
      SECRETION OF GLUCAGON-LIKE PEPTIDE-1 AND REACTIVE HYPOGLYCEMIA AFTER PARTIAL GASTRECTOMY

      Digestion
    46. RITZEL R; ORSKOV C; HOLST JJ; NAUCK MA
      PHARMACOKINETIC, INSULINOTROPIC, AND GLUCAGONOSTATIC PROPERTIES OF GLP-1-[7-36 AMIDE] AFTER SC INJECTION IN HEALTHY-VOLUNTEERS

      Diabetologia
    47. NAUCK M; ERPENSTEIN A; HOLST JJ; ORSKOV C; VONBOXBERG C; WIRTZ G; TILLIL H; KOBBERLING J; CREUTZFELDT W
      RELEASE OF GLP-1-[7-36 AMIDE] AFTER ORAL GLUCOSE IN RELATION TO GLUCOSE-TOLERANCE AND SEX

      Diabetologia
    48. WILLMS B; WERNER J; CREUTZFELDT W; ORSKOV C; HOLST JJ; NAUCK M
      INHIBITION OF GASTRIC-EMPTYING BY GLUCAGON-LIKE-PEPTIDE (7-36) AMIDE IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS

      Diabetologia
    49. ORSKOV C; RABENHOJ L; WETTERGREN A; KOFOD H; HOLST JJ
      TISSUE AND PLASMA-CONCENTRATIONS OF AMIDATED AND GLYCINE-EXTENDED GLUCAGON-LIKE PEPTIDE-I IN HUMANS

      Diabetes
    50. WILLMS B; WERNER J; CREUTZFELDT W; ORSKOV C; HOLST JJ; NAUCK M
      INHIBITION OF GASTRIC-EMPTYING BY GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDEIN PATIENTS WITH TYPE-2 DIABETES-MELLITUS

      Diabetes
    51. NIELSEN FC; ORSKOV C; HASELBACHER G; RAMLAU J; CHRISTIANSEN J; SCHMIEGELOW K; REHFELD JF
      INSULIN-LIKE GROWTH-FACTOR-II MESSENGER-RNA, PEPTIDES, AND RECEPTORS IN A THORACOPULMONARY MALIGNANT SMALL ROUND-CELL TURNER

      Cancer
    52. NAUCK MA; BUSING M; ORSKOV C; SIEGEL EG; TALARTSCHIK J; BAARTZ A; BAARTZ T; HOPT UT; BECKER HD; CREUTZFELDT W
      PRESERVED INCRETIN EFFECT IN TYPE-1 DIABETIC-PATIENTS WITH END-STAGE NEPHROPATHY TREATED BY COMBINED HETEROTOPIC PANCREAS AND KIDNEY-TRANSPLANTATION

      Acta diabetologica
    53. GOKE B; GOKE R; HOLST JJ; ORSKOV C
      GLUCAGON-LIKE PEPTIDE-1 - ON ITS WAY TO CLINICAL-APPLICATION

      Digestion
    54. ORSKOV C; WETTERGREN A; RABENHOJ L; HOLST JJ
      A COMPARISON OF THE PRODUCTION, SECRETION AND EFFECTS OF GLUCAGON-LIKE PEPTIDE 1(7-36)AMIDE AND GLP-1(7-37)

      Digestion
    55. HOLST JJ; HVIDBERG A; NIELSEN MT; HILSTED J; ORSKOV C
      EFFECT OF GLUCAGON-LIKE PEPTIDE-1 ON GLUCOSE-TURNOVER IN NORMAL MAN

      Digestion
    56. WETTERGREN A; SCHJOLDAGER B; MORTENSEN PE; PETERSEN H; ORSKOV C; HOLST JJ
      EFFECT OF GLP-1 ON GASTRIC-MOTILITY AND GASTRIC AND PANCREATIC-SECRETION IN MAN

      Digestion
    57. MIHOLIC J; ORSKOV C; HOLST JJ; SCHAPER S
      POSTPRANDIAL GLP-1 IN PATIENTS AFTER ESOPHAGEAL RESECTION, TOTAL GASTRECTOMY AND MASSIVE SMALL-BOWEL RESECTION

      Digestion
    58. NAUCK MA; KLEINE N; ORSKOV C; HOLST JJ; WILLMS B; CREUTZFELDT W
      NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE 1(7-36)AMIDE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS

      Digestion
    59. MIHOLIC J; ORSKOV C; HOLST JJ; KOTZERKE J; PICHLMAYR R
      POSTPRANDIAL RELEASE OF GLUCAGON-LIKE PEPTIDE-1, PANCREATIC GLUCAGON,AND INSULIN AFTER ESOPHAGEAL RESECTION

      Digestion
    60. NAUCK MA; KLEINE N; ORSKOV C; HOLST JJ; WILLMS B; CREUTZFELDT W
      NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS

      Diabetologia
    61. WILLMS B; KLEINE N; ORSKOV C; HOLST JJ; NAUCK MA; CREUTZFELDT W
      NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLP-1 (7-36 AMIDE) IN TYPE-2-DIABETIC

      Diabetologia
    62. NAUCK MA; FIESELER P; ORSKOV C; HOLST JJ; NUSTEDE R; MARTELL J
      INSULINOTROPIC ACTIONS OF GIP AND GLP-1 (7-36 AMIDE), BUT NOT OF CCK-8 AT PHYSIOLOGICALLY ELEVATED AMINO-ACID-CONCENTRATIONS

      Diabetologia
    63. HEINZE E; CLARK PMS; HALES CN; ORSKOV C; EBERT W; HOLL RW
      REDUCED GIP CONTRIBUTES TO ALTERED INSULIN-RESPONSE FOLLOWING ORAL GLUCOSE IN WOMEN WITH TURNER SYNDROME

      Diabetologia
    64. ORSKOV C; WETTERGREN A; HOLST JJ
      BIOLOGICAL EFFECTS AND METABOLIC RATES OF GLUCAGON-LIKE PEPTIDE-1 7-36 AMIDE AND GLUCAGON-LIKE PEPTIDE-1 7-37 IN HEALTHY-SUBJECTS ARE INDISTINGUISHABLE

      Diabetes
    65. NAUCK MA; KLEINE N; ORSKOV C; HOLST JJ; WILLMS B; CREUTZFELDT W
      NORMALIZATION OF FASTING HYPERGLYCEMIA BY EXOGENOUS GLP-1 [7-36 AMIDE] IN TYPE-2-DIABETIC PATIENTS

      Diabetes
    66. KARLSEN C; ORSKOV C; ROUILLE Y; WESTERMARK G; NIELSEN E; STEINER DF; HOLST JJ; MADSEN OD
      ARE PROPROTEIN CONVERTASES PC2 AND PC3 INVOLVED IN PROGLUCAGON PROCESSING

      Diabetes


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/01/21 alle ore 04:15:09